An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.
- Status
- COMPLETED
- Phase
- N/A
Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- NA
Photochemical Tissue Bonding
- Status
- COMPLETED
- Phase
- PHASE2
Spectroscopy With Surface Coils and Decoupling
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
- Status
- COMPLETED
- Phase
- NA
Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
- Status
- COMPLETED
- Phase
- N/A
Identification of Key Blood Molecular Markers for Immunotherapy
- Status
- TERMINATED
- Phase
- N/A
Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
- Status
- COMPLETED
- Phase
- PHASE2
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
- Status
- COMPLETED
- Phase
- PHASE3
PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE1
MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE1
Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva
- Status
- UNKNOWN
- Phase
- N/A
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2